Eve Air Mobility Narrows Q2 Loss to $34.2M and Achieves First Transition Flight
EVEX sits 16% above its 52-week low of $2.1.
Summary
Eve Holding reported a narrower Q2 loss of $34.2 million and achieved its first partial transition flight, a key eVTOL milestone, while maintaining strong liquidity through 2028.
Key Events · Earnings and Guidance · EVEX
-
First Transition Flight Achieved
On August 3, Eve's engineering prototype completed its first partial transition flight, activating the rear pusher propeller and reaching 30 knots — a critical step toward wing-borne flight and certification.
-
Q2 Loss Narrows to $34.2M
Net loss improved to $34.2 million from $64.7 million in Q2 2025, driven by a 37% drop in R&D expenses to $28.9 million due to better supplier negotiations.
-
Cash Runway Through 2028
Total liquidity stood at $531.3 million at quarter-end, including $403.3 million in cash and investments; full-year 2026 cash consumption guidance of $225–$275 million remains on track.
-
$13.5B Order Pipeline
Non-binding backlog of ~2,700 eVTOL units valued at ~$13.5 billion, with 28 customers across nine countries; a new LOI for 30 aircraft was signed with Moov in Q2.
Analysis · EVEX · Manufacturing
The real headline is the August 3 first partial transition flight — a critical technical milestone that moves the eVTOL program from hover to wing-borne flight, de-risking the certification path. Financially, Eve's Q2 results show a sharply narrower loss of $34.2 million, down from $64.7 million a year ago, as R&D costs fell on better supplier terms. Cash burn was $49.4 million, and the company reiterated full-year consumption of $225–$275 million, with liquidity of $531 million providing runway through 2028. With a $13.5 billion non-binding order book and ANAC noise criteria published, Eve is executing on both financial discipline and technical milestones, strengthening its position in the urban air mobility race.
At the time of this filing, EVEX was trading at $2.44 on NYSE in the Manufacturing sector, with a market capitalization of approximately $835.9M. The 52-week trading range was $2.10 to $6.89. This filing was assessed with positive market sentiment and an importance score of 8 out of 10.